As most people can attest, making any kind of decision can be difficult. Contemplating the menu in your favorite restaurant may be a lengthy process, but failing to make the optimum choice is rarely serious. When it comes to delivering the best outcomes for your patients, choosing the optimum option is the only option. Today’s cataract surgeons are presented with an increasingly long menu of IOLs – and the process of navigating the technological landscape and deciding which options work best is becoming increasingly complicated.
Enter RayPRO+ – a one-of-a-kind digital platform free to Rayner lens users that proactively collects an insightful blend of long-term patient reported outcomes (PROs) to provide you with the data you need to make informed decisions when selecting IOLs for your patients.
Developed specifically for ophthalmic surgeons who perform cataract surgery, RayPRO+ provides increased insight into surgical and service performance with little effort by clinical staff. Patients can be registered on RayPRO+ within seconds, alongside the details of the lens used in the surgery; notably, this isn’t just for Rayner lenses – the platform is lens agnostic. Following surgery, patients are invited to confidentially answer five short online questionnaires over the course of three years about their satisfaction, spectacle independence, dysphotopsias and follow- up procedures. RayPRO+ then analyzes these responses and displays aggregated trends about patients, clinics, and IOLs via web browser or an intuitive app available to both iOS and Android users
RayPRO+ has been constructed with several features intended to add as much value as possible to the clinical workflow of the surgeon. The account managed service allows for comparative data analysis – including both comparison of IOL outcomes data between different manufacturers and peer comparison based on patient outcomes – and supports the data provided being used for marketing purposes, clinical studies and as evidence during appraisals and recertification. Alongside the information it provides, RayPRO+ also aids its users in auditing IOL usage and promotes surgical services to new patients.
The only service of its kind, RayPRO+ redefines the space, but Rayner is not complacent; rather it is committed to continually refine the platform. After all, it is only fitting that, as IOL technology choice grows, so should the surgeon’s ability to navigate all the options to make the correct decision for themselves and their patients.
